West Virginia Medical Journal - 2024 - Quarter 3 | Página 14

NEWS

Marshall University Joan C . Edwards School of Medicine
Marshall University ALS Clinic Named First ALS Association Recognized Treatment Center in West Virginia
The Marshall University Amyotrophic Lateral Sclerosis ( ALS ) Clinic , jointly operated by Marshall Health Network and Marshall University , has been named the first ALS Association Recognized Treatment Center in West Virginia ( WV ). The multidisciplinary clinic , established in 2018 , is one of only 100 treatment centers recognized by the ALS Association in the United States ( US ). It serves as a regional hub for ALS care , offering comprehensive care to patients , including medical management , rehabilitation , clinical trials , and access to FDA approved treatments . Additionally , the center provides educational resources and support programs to patients , caregivers , and healthcare professionals .
Marshall Health Now Prescribes the First FDA- Approved Liver Disease Medication , Offering the Most Advanced Liver Disease Screening
The first and only medication for liver fibrosis caused by metabolic dysfunction-associated steato hepatitis ( MASH ) is now available through Marshall Health . Rezdiffra ( resmetirom ), approved in March 2024 by the U . S . Food and Drug Administration , is used along with diet and exercise to treat adults with MASH who have moderate to advanced liver scarring .
Marshall Health also offers FibroScan , the most advanced non-invasive screening to determine liver damage and FDA-approved eligibility for this new treatment . As one of the first in the US and the only health system in West Virginia to utilize the latest FibroScan technology ( Guided VCTE ), Marshall Health can scan more patients in less time with greater accuracy . FibroScan screening options through Marshall Health Network are available at Cabell Huntington Hospital ( CHH ) in Huntington and Marshall Health — Teays Valley in Putnam County , WV . The new technology of FibroScan coupled with national clinical trial results for Rezdiffra that showed improvements to the fibrosis represents pivotal innovations in the diagnosis and treatment of liver disease .
Patients not eligible for the new medication may still be referred to Marshall Health ’ s liver clinic for help with weight loss and other liver disease management methods . For additional information , call Marshall Internal Medicine at ( 304 ) 691-1000 .
School of Medicine Welcomes More New Resident Physicians and Fellows , Including First Rural Psychiatry Residents
More than 100 incoming resident physicians and fellows officially began their post-graduate medical training this summer at the Marshall University Joan C . Edwards School of Medicine . The new cohort of trainees hails from 64 medical schools across 19 states and 21 countries . This includes 31 trainees who are medical alumni from WV ’ s three medical schools .
Among the new trainees are four rural psychiatry residents participating in a new four-year residency program . Under
12 • www . wvsma . org